Spinal Muscular Atrophy Trial, Recruiting NCT07521930 Sponsor: Johns Hopkins University Condition: Spinal Muscular Atrophy
Back to Spinal Muscular Atrophy

Spinal Muscular Atrophy Trial, Recruiting

NCT07521930
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have significant weakness or loss of movement in both arms (and possibly legs), or severe problems with coordination, due to a confirmed medical condition.
  • Your condition is caused by a brainstem stroke, a traumatic spinal cord injury, or a progressive muscle or nerve disease such as muscular dystrophy or ALS (Lou Gehrig's disease).
  • You may also qualify if your movement problems are combined with severe difficulty speaking, such as in Locked-In Syndrome or ALS.
  • If your condition is from a spinal cord injury, it must affect the neck area (C6 level or higher) and be rated A, B, or C on a standard injury scale.
  • If your condition is from a spinal cord injury or a non-progressive cause, the strength in each of your arms must be very limited (scored 7 or below on a standard scale), and your leg strength must be below the ability to lift against gravity.
  • If you have a progressive condition like ALS, your arm strength must also be below the ability to lift against gravity.
  • Your movement problems must have lasted at least 12 months before joining, if caused by a non-progressive condition like stroke or spinal cord injury.
  • You have been cleared as safe for surgery by your own doctor and the study medical team.
  • You are able to communicate reliably, for example through speech or eye movements.
  • You have a stable support system at home, including a caregiver who can monitor you throughout the study.
  • You are able and willing to travel to the study location up to five days per week for the full duration of the study.
  • You are able to understand and follow instructions during study sessions.
  • Your vision (with glasses or contacts if needed) is good enough to use a computer screen.

Who may not be able to join:

  • You have a psychiatric condition or memory/thinking problems that would make it difficult to give informed consent or fully participate.
  • You have an active implanted medical device, including any device that cannot safely be used near an MRI machine.
  • You have a medical reason why you cannot have an MRI, or you are likely to need an MRI during the study period.
  • You have serious heart, lung, kidney, or metabolic health problems that would make surgery unsafe.
  • You take blood thinners regularly and cannot safely stop them for surgery.
  • You have conditions that make having a long-term implanted device unsafe, such as bone infection, chronic infection, poorly controlled diabetes, cancer, severe autoimmune disease, epilepsy, or poor wound healing.
  • You have tooth decay or a significant risk of dental or gum infection.
  • You regularly take steroid medications or drugs that suppress your immune system, either by mouth or through an IV.
  • You have had active cancer in the past year or are currently receiving chemotherapy.
  • You have had episodes of uncontrolled autonomic dysreflexia (a sudden dangerous rise in blood pressure) in the past 3 months (confirm with trial site).
  • You have a condition involving excess fluid around the brain (hydrocephalus), with or without a surgically implanted shunt.
  • You have other ongoing, unstable health conditions that could interfere with your participation.
  • You have had persistent thoughts of suicide in the past 12 months.
  • You have had a substance use disorder in the past year.
  • You are currently pregnant (confirmed by a blood test).
  • You are currently breastfeeding, planning to become pregnant, or not using a reliable form of birth control.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Nathan Crone, MD, Johns Hopkins University

Phone: 4109559441

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 August 2026
Est. completion
1 June 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Incidence of Device-Related Adverse Events [Safety and Tolerability]

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov